[HTML][HTML] Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics
Lipid-based polymeric nanoparticles are the highly popular carrier systems for cancer drug
therapy. But presently, detailed investigations have revealed their flaws as drug delivery …
therapy. But presently, detailed investigations have revealed their flaws as drug delivery …
Recent advances in multifunctional dendrimer‐based complexes for cancer treatment
D Shcharbin, V Zhogla, V Abashkin… - Wiley …, 2024 - Wiley Online Library
The application of nanotechnology in biological and medical fields have resulted in the
creation of new devices, supramolecular systems, structures, complexes, and composites …
creation of new devices, supramolecular systems, structures, complexes, and composites …
Dendrimer platform against prostate cancer: Recent update on new horizon of treatment
M Pandey, HX Lang, JS Loh, YL Chai, HL Tee… - Journal of Drug Delivery …, 2023 - Elsevier
Prostate malignancy is regarded as one of the most lethal disorders in men. In the last two
decades, new cases of prostate cancer have risen swiftly worldwide. Currently, the …
decades, new cases of prostate cancer have risen swiftly worldwide. Currently, the …
Nanotherapeutics for prostate cancer treatment: A comprehensive review
R Hu, J Lan, D Zhang, W Shen - Biomaterials, 2024 - Elsevier
Prostate cancer (PCa) is the most prevalent solid organ malignancy and seriously affects
male health. The adverse effects of prostate cancer therapeutics can cause secondary …
male health. The adverse effects of prostate cancer therapeutics can cause secondary …
Programmed nanocarrier loaded with paclitaxel and dual-siRNA to reverse chemoresistance by synergistic therapy
M Zhang, X Zhang, S Huang, Y Cao, Y Guo… - International Journal of …, 2024 - Elsevier
Paclitaxel (PTX) is commonly used in clinical tumor therapy. However, chemoresistance and
the inducement of tumor metastasis severely affect the efficacy of PTX. To develop a …
the inducement of tumor metastasis severely affect the efficacy of PTX. To develop a …
αvβ3 integrin-targeted pH-responsive dendritic nanocarriers for enhanced anti-tumor efficacy of docetaxel against breast cancer
The hyperbranched biodegradable dendrimer (Boltron® H40) has received mounting
attention as a result of its efficient encapsulation of therapeutic molecules and sustained …
attention as a result of its efficient encapsulation of therapeutic molecules and sustained …
MUC1 aptamer-tethered H40-TEPA-PEG nanoconjugates for targeted siRNA-delivery and gene silencing in breast cancer cells
With a prevalence of 12.5% of all new cancer cases annually, breast cancer stands as the
most common form of cancer worldwide. The current therapies utilized for breast cancer are …
most common form of cancer worldwide. The current therapies utilized for breast cancer are …
[PDF][PDF] Initial version before any revisions
D Shcharbin, V Zhogla, V Abashkin, Y Gao, JP Majoral… - researchgate.net
The application of nanotechnology in biology and medicine induced the appearance of new
devices, supramolecular systems, structures, complexes and composites. Dendrimers are …
devices, supramolecular systems, structures, complexes and composites. Dendrimers are …